GlassScriptPhysician profile
Salim Ibrahim Dib
NPI 1609098896
$1,734.21
in general payments reported to CMS, 2019-2025
7 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $181 · 2023: $663 · 2024: $712 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198 · Education: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.03 |
| Education | $354.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $984.99 | 2022-2025 | Wakix |
| Resmed Corp | $238.69 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $230.08 | 2022-2024 | |
| Idorsia Pharmaceuticals US INC | $119.38 | 2023-2024 | Quviviq |
| Fisher & Paykel Healthcare INC | $68.30 | 2024-2025 | Fisher & Paykel Healthcare |
| Axsome Therapeutics, INC. | $50.94 | 2024 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $41.83 | 2023-2024 | Lumryz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salim Dib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.